Lucem Health, a Davidson, North Carolina-based provider of innovative clinical AI technology and solutions, has recently announced that it has closed a Series A funding round worth $7.7 million. The funding was led by renowned healthcare organizations such as Mayo Clinic, Granger Management, and Mercy (St Louis), as well as existing investor Rally Ventures.
The newly raised funds will enable Lucem Health to advance the development of its clinical AI platform, expand its solution portfolio, and strengthen its sales and marketing efforts. Lucem Health aims to revolutionize the healthcare industry by integrating powerful AI-generated insights into care delivery workflows in a responsible and thoughtful way.
According to Sean Cassidy, founding CEO of Lucem Health, "AI has tremendous potential to transform and augment how physicians and providers practice medicine, make decisions, and serve their patients. Yet, so far, we have barely scratched the surface of AI's potential in healthcare. We started Lucem Health to accelerate the integration of innovative, trusted solutions that can detect diseases earlier and optimize care delivery, positively impacting patient lives, improving the physician and provider experience, and ultimately producing improved outcomes."
Lucem Health helps clinical AI innovators transform data science into trusted solutions that can improve patient lives by detecting diseases earlier and optimizing care delivery. By integrating powerful AI-generated insights into care delivery workflows, Lucem Health aims to improve the physician and provider experience and ultimately produce improved outcomes.
The recent funding round led by reputable healthcare organizations is a testament to the potential of Lucem Health's innovative platform and solutions. With the newly raised funds, Lucem Health is poised to make significant strides in advancing the use of clinical AI in healthcare and improving patient outcomes.
